Argentina starts trials on hyperimmune equine serum

Argentina on Wednesday began clinical trials for treating COVID-19 with hyperimmune equine serum. The serum, produced by biotechnology company Inmunova, is developed with antibodies from horses, lab officials said. A total of 242 coronavirus patients with moderate to severe conditions will participate in the trial.